A detailed analysis of the structure and fu nction of negative· strand RNA virus proteins and their interactions with one another in the replicative cycle has suffered from the lack of a method for genetic manipulation. Introduction of site· directed alterations in genomes of negative·stranded RNA viruses has been li mited because the naked ge nomic RNA is not biologically active or infectious. The functional template for transcription and re plication is the nucleocapsid structure that contains the genomic RNA encapsidated with nucleo· capsid protein. Several different approac hes are now avail· able to ge nerate viral ge nomic RNAs from cDNA clones in vitro. However, for negative·strand viruses, these ge nomic RNAs must be assembled into nucleocapsid structures to obtain biological activity. The difficulty in ge nerating biologically ac ti ve nucleocapsids of negative·strand RNA viruses has provided a major stumbli ng block for detailed genetic analysis of this group of viruses. Only recently, synthetic transcripts representing the ge nomic RNAs of two negative· strand RN A viruses. measles and influenza, have been assembled into biologicall y active nucleocapsids (1-3). These
The publication costs of this article wen: def11lyed in part by page charge payment. Thi s article must therefore be hen:by marked " Udvl'rliJl'mprll" in accordance with 18 U.S.C. U734 solely to indicate this fac !. 1379 accomplishments hold great promise as experimental systems for genetic manipulation of negative·strand virus genomes. In both cases, however, the success of the system was closely tied to the biology of the virus. Therefore, alternative approaches to study structure-function analysis of viral proteins would be useful.
Vesicular stomatitis virus (VSV), a rhabdovirus, contains fi ve structural proteins and each of these proteins plays a role in replication, assembly. and budding ofVSY . The genomic RNA of VSV is a single-stranded 1l ,161-nucleotide-long RNA (4, 5) of negative polarity, which is encapsidated with the nucleocapsid protein (N) as a nucleocapsid structure. The active te mplate for transcription and replication is the nucleocapsid structure that contains two other minor proteins, the phosphoprotein (NS) and the large polymerase protein (l ), both of which are required for the RN A polymerase activity ofVSV (6-8) . These three proteins-namely, the N, NS, and l proteins-are the only proteins that are required for transcription and replication of VSV (8) . The ectodomain of the glycoprotein (G) 'of VSV forms the spikes on the viral envelope and interacts with virus receptors on susceptible cells (9) . There is evidence that the cytoplasmic domain of the G protein is required for assembly of VSV (10, 11) . Several lines of evidence indicate that the matrix protein (M) plays a crucial role in the assembly and budding processes of VSY. The M protein assembles at the inner surface of the plasma membrane and is thought to interact with the G protein and the viral nucleocapsid structures (12) (13) (14) (15) . The M protein is also involved in the condensation of nucleocapsids into the tightly coiled structu res that are found in mature virions (16, 17) .
In this communication, we describe an alternative approach to the study of YSV proteins and their interactions with each other during replication, asse mbl y, and budd ing of VSV . We have previously shown that transfection of plasmid DNAs containi ng VSV genes under the control ofa 17 RNA polymerase promoter into cells infected wit h a re combinant vaccinia virus that contains and expresses the gene for bacteriophage 17 RNA polymerase results in high-level expression of the VSV proteins (8) . Coexpression of the N, NS, and L proteins of YSV in cells allows rep lication and amplification of defective interfering (OJ) particle RNA of VSV (8) . We and others have also shown that the G and M proteins can be expressed in fu nctional forms by using the same expression system (11 , 18-20 assembly. and budding of infectious DI particles from these cells. This system will allow us 10 study detailed struclUrefunction aspects of each of the viral proteins and the role of these proteins in each step of the viral replicative cycle.
MATERIALS AND METHODS
Cell Cultures and Viruses. Baby hamster kidney cells were maintained as monolayer cultures in minimal essential medium (MEM ) containing 5% heal·inactivated felal bovine serum and 5% newborn calf serum. VSV (lndi· ana serOlype. San Juan strain) was propagated in BHK-2 1 cells. Stocks of DI-T particles (21) were prepared as described (8), Recombinant vaccinia virus (vTF7-) containing the T1 RNA polymerase gene has been described (22) and was kindly provided by Bernard Moss (National Institutes of Health , Bethesda, MD). StocksofvTF1-3 were prepared and infectivity titers were determined as described (8) .
PllISmid Vectors and cDNA Clones . The plasmids pAP·N. pMB-NS , and pAP-L contai ning the N gene, the NS gene, and the L gene , respectively , have been described (8) . The plasmid pKOM2 containing the wild·type M gene (Indiana serotype) inserted into the pGEM4XB vector has been described (23) and was kindly provided by Manfred Schubert (Nalionallnsti tutes of Health). This plasmid contains the M gene under the control ofTI RN A polymerase promoter. The plasmid pTF·G contains the VSV G ge ne (Indiana serotype) under the conlrol of the TI RNA polymerase promoter and transcriptional terminator in pTF1-5 (24). This plasmid was kindly provided by M. Abdul Jabbar (Uni veN;ity of California-Los Angeles , Los Angeles). Plasmids were prepared and purified as described (25) .
Virus Infection, DNA Transfection, and Radioactil'e Label· ing. BHK-2 1 cells in 6()..mm plates were infected with the recombinant vaccinia virus vTF1·3 and transfected with plasmid DNA using the calcium phosphate precipitation method as descri bed (8 . 26) . Radioacti ve labeling of proteins with [l'Slmethionine (20~C i / ml : I Ci = 37 G8q)and of RNA with IlH]uridine (20 ~Ci / ml) was also performed as detailed (8) .
Immunoprecipitalion and Electrophoretic Analysis or Pr0-teins. Cytoplasmic extracts of cells were prepared and virus· specific proteins were immunoprecipilaled as described (8) by using either a mouse pol yclonal antiserum raised against purified VSV or a monospecific rabbit antibody raised against an amino-terminal peptide from the L protein (27) kindl y supplied by Manfred Schubert or both. Proteins were analyzed by electrophoresis in 10% polyac rylamide gels by using the buffer system of Laemmli (28) and detected by flu orograph y (29).
Analysis of DI Particle RNA Replication . Replication of 01 particle RNA was analyzed by immunoprecipitation of nucleocapsids as described (8) . IJHIUridine·labeled RNAs recovered from immunoprecipitated nucleocapsids were resolved by electrophoresis in 1.75% agarose/ citrate/ urea gels (30) and detected by flu orography (31).
Electron Microscopy. 01 particles generated from cell s coinfected with helper VSV and 01 particles or from cells expressing all fi ve VSV proteins were analyzed by transmi s· sion electron microscopy. Clarified culture fluids were pelleted through a cushion of 5% sucrose in 10 mM Tris·HCI . pH 7.4/ 100 mM NaCI/l mM EOTA (NTE). The pellets were resuspended in NTE, and aliquots of each sample were negatively stained with uranyl acelate and visualized by using a Phillips 301 transmission electron microscope.
Antibodies. Anti·VSV antibodies were raised in mice against gradient-purified VSV. The monoclonal anti body (DC3) to the G protein was kindl y provided by Richard Compans (U niversity of Alabama at Birmingham). The monoclonal antibodies (1004. 22F9. 19810 . and 8CllFIO) to Proc. NtJ ti. Acad. Sci. USA 88 (1991) the VSV N protein were a generous gift rrom D. Lyles (Wake Forest University. Winston·Salem . NC).
RESULTS
Expression of Viral Proteins in Transrected Cells. We have previously shown (8) that the N protein. the NS protein , and the L protein of VSV can be coexpressed in HEp·2 cells by cotransfection of plasmids containing the individual VSV genes using the recombinant vaccinia virus-TI RNA pol ymerase expression system (22). The N, NS. and L proteins expressed in this manner were shown to support replication orDl particle RNA (8). Here we determined whether all five VSV protei ns could becoexpressed in cells by cotransfection of plasmids containing the genes for each or the five VSV proteins. BHK·21 cell s cotransfected with plasmids contain· ing the individual VSV genes we re labeled with IlsS]methionine. Total cytoplasmic proteins or immunoprecipitated pro· teins from cytoplasmic extracts were analyzed by SOS/ PAGE . All fi ve VSV proteins were coexpressed in cultures cotransfected with all five plasmids ( Fig. 1. lanes 4 and 7) . replication, assembly, and budding was examined, The DI particles cannot replicate on their own because they do not contain the genetic information to code for any functional VSV proteins, Normally, coi nfection with helper virus is required to provide the functional viral proteins for replication, assembly, and budding of the 01 particles, The protocol to analyze assembly and budding of DI particles from cells expressing viral proteins is as follows. Cells infected with vTF7·3 were transfected with various combinations of plasmid ONAs containing the individual genes for the VSV proteins. At 5 hr after transfection. the cells were superinfecled wilh 01 particles. After vi rus adsorption, the cells were washed twice in warm MEM and then incubated al370C with I ml of MEM. Culture fluids from these cells (passage 1) were collected at 20-24 hr after OJ particle superinfection and clarified by centrifugation at 16 .000 x g for 1 min at4QC. Half (500 ~I) of the clarified culture fluids was used to infect (as in passage 1) a second set of cells (passage 2) that had been infected with vTF7-3 and transfected with the same combi· nation of plasmid DN As as in the first passage. Culture fluid s from passage 2 were collected at 20-24 hr after infection and clarified as above. It was necessary to carry out two passages to avoid the possible carry-over of any OJ particles used in the primary infection that may have been present in passage I culture fluid s due to the release of adsorbed DI particles that did not penetrate the cells. The presence of infectious 01 particles in the culture fluids from passage 2 cells was assayed by the RNA replication assay (8) in cells expressing the N. NS, and L proteins of VSV. After two passages, OJ particles were not detected in the culture fluids of cells that did not express any viral proteins (Fig. 2, lane 2) or cells that expressed only the N, NS, and L proteins (lane 3). Expression of the N, NS, and L proteins in combination with either the M or G proteins also did not support viral budding (Fig.  2, lanes 4 and 5, respecti vely) . OJ panicles were detected, however. in the culture fluids of cells that expressed the M and G proteins in addition to the N, NS , and L proteins (lane 6). These results show that DI particle budding occurred only when all five VSV proteins were coexpressed and that the M and G proteins are required for assembly and budding of infectious OJ panicles.
To demonstrate that the vector-supported budded 01 par· ticles were mature particles containing the viral G protein in the envelope with the nucleocapsids enclosed inside, we tested antibodies against the G or N protein or against all five VSV proteins for their ability to block the infectivity of the vectorsupported budded panicles present in the culture fluid s. Purified authentic 01 panicles or the budded panicles from culture fluids of cells expressing all five VSV proteins were treated separately with antibodies raised against VSV, a monoclonal antibody to the G protein, or a combination offour monoclonal antibodies to the N protein. The monoclonal antibody to the G protein neutralizes the infecti vity of VSV (unpublished result). The monoclonal antibodies to the N protein are known to bind nucleocapsids (J. Glass and G.W.W., unpublished observation) and previous work has shown that such anti-N monoclonal antibodies block the transcription and replication capabilities of nucleocapsids (32) . The ability of antibody-treated OJ particles and vectorsupported budded particles in the culture fluid s to direct replication of their genomic RNA was examined in cells that were infected with helper VSV. The results in Fig. 3 show that anti-VSV and anti-G antibodies inhibited the genomic RNA replication of authentic OJ particles used as a control (lanes 2 and 3) as well as Ihat of the DI particles budded into the culture fluid s of cells expressing all five VSV proteins (lanes 6 and 7). However, the anti·N antibodies (lanes 4 and 8) had no effe<:t on infectivity, and RNA replication directed by both types of 01 particles was observed at levels similar to those obtained in the absence of the antibodies (lanes 1 and 5) together. these results indicate that the particles that are present in the culture fluids of cells expressing all five VSV proteins contained G protein on the surface of the envelope and that the nucleocapsid structures were enclosed within the envelope in a manner similar to that of the authentic OJ particles generated from cells coinfected with helper VSV.
The presence of budded OJ particles in culture fluids was also examined by electron microscopy. The culture fluid s of cells coinfected with helper VSV and Dl particles contained a large number of DI particles in addition to some VSV particles (Fig. 4A) . These Dl particles were approximately one·third of the size of the typical bullet-shaped wild·type VSV particles and appeared to be spherical. Particles similar in size and morphology to the authentic 01 particles were also seen in the culture fluid s of cells eXpressing all five VSV proteins (arrows in Fig. 48 ). Culture fluid s of vTF7-3-infected cells expressing only the N, NS, and L proteins did not contain any particles similar to authentic OJ particles (data not shown). The number of particles generated from cells expressing all five VSV proteins amounted to 5-10% of the OJ particles generated from helper VSV-coinfected cells.
DISCUSSION
In this report, we demonstrate that cells eXpressing all five structural proteins of VSV from cloned cON As, when in· fected with OJ particles. allow replication, assembly, and Fig. 2 . lane 6. were treated with no antibodies (lanes 1 and S), anti-VSV antibod y (l:2S dilution; lanes 2 and 6), monoclonal antibody DC), to the G protein (1:2S dilution; lanes) and 7), or a combination offour monoclonal antibodies to N protein (l:.50dilution of each: lanes 4 and 8) for 2 hr at 4"C. The D1 stock virus or culture fluids were then used in the RNA replication assay in cells infe<:ted with helper VSV as described (8) .
budding of infectious 01 particles. Expression of all five VSV proteins is absolutely required for 01 panicle assembly and budding since expression of the N, NS, L, and either the M or G proteins did not suppon panicle budding. The infectivity of these particles could be neutralized by anti-VSV and anti-G antisera but not by anti-N antiserum. indicating that these particles contained G protein on the envelope with the nucleocapsid enclosed inside. The panicles were also similar in size and morphology to the authentic 01 panicles generated from cells coinfected with helper VSV.
Cotransfection with plasmid DNAs containing all fi ve VSV ge nes resulted in synthesis of all five VSV proteins. The molar ratios oftheG, N, and M proteins in cells coexpressing all five VSV proteins were comparable to those of the cells infected with VSV. The NS and L proteins, however, were synthesized in amounts that were less than those seen in VSV -infected cells. In previous work. we showed that in cells cotransfected with plasmids bearing the genes for the N. NS, and L proteins, expression of one protein did not interfere with the expression of other VSV proteins (8). This. however, was not found to be the case in cells coexpressing all five VSV proteins. Coexpression of M protein with other VSV proteins led to inhibition of expression of other VSV proteins. This result is intriguing, panicularly in the context of the vaccinia virus TI-RNA polymerase expression system, since the M protein has been shown to inhibit VSV RNA transcription by condensing the nucleocapsids into transcriptionally inactive forms (33) (34) (35) . In VSV-infected cells, VSVspecific proteins are synthesized by polyribosomes in association with the cytoskeletal framework (36) and it has been postulated that the M protein may disrupt the cytoskeletal framework (23) . It is possible. therefore, that the M protein inhibits the expression of other VSV proteins at the level of translation. Further experiments are required to examine the mechanism of inhibition of protein expression by the M protein.
We have shown previously that the level of proteins in transfected cells can be controlled by the amount of DNA plasmid transfected into the cell. Therefore, it shou ld be possible to increase the expression of the NS and L proteins by increasing the amount of the corresponding plasmid DNAs in transfection such that the molar ratios of all five VSV proteins are comparable to those seen in VSV-infected cells. Nevertheless, the levels of proteins synthesized in cells transfected with all five plasmids under the conditions used here supported replication , assembly, and budding of DI particles. DI particle budding from cells expressing all five VSV proteins was readily detectable using the RNA replication assay and the number of budded particles represented 5-10% of those obtained from helper VSV-coinfected cells. Using HEp-2 cells, we have shown previously that the amount ofDl particle RNA replication in cells expressing the N, NS, and L protei ns is 8-10 times more than that in cells infected with VSV (8) . However, in BHK-21 cells (used here because they are stable to long-term vaccinia virus infection) the amount of DI particle RN A replication in cells expressing the three VSV proteins is less than that in cells infected with VSV (unpublished observation). The reduced level of vectorsupponed budding of DI particles may be a result of the reduced level of RNA replication in BHK-21 cells or due to synthesis of suboptimal levels of the fi ve VSV proteins or both. The fraction of the cells that express all five VSV proteins has not been determined yet but this would influence the number of cells that would support Dl particle budding. We determined previously that -40% of the cells in culture coexpressed the N, NS, and L proteins when cotransfected with the corresponding plasmid DNAs (8) .
Using the vaccinia virus-T7 RNA polymerase expression system, Li et al. (19, 20) heterologous glycoproteins or chimeras between VSV G protein and other viral g1ycoproteins shou ld provide information on the mechanisms of generation of viral pseudo· types. Furthermore, in VSV-infected cells positive-and negative-strand RNAs are encapsidated but only the nucleocaps ids contain ing the negative-strand RNA are incorporated into budded virions. The mechanism by which this selection is exerted is not known at present but can be addressed by experiments using the system we have described above. Most importantly, the system we have described above provides the ability to make specific changes in each of the individual proteins of VSV and to study the role of the viral proteins in each step of the replicative cycle of VSV-that is, replication, assembly, and budding. In addition . it is anticipated that this system should be applicable to other negative-strand virus systems for which complete cDNA copies of the viral genes are available.
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